For Younger Women, Study Reveals Mammography Saves Lives
By MedImaging International staff writers Posted on 11 Feb 2014 |

Image: Mammography unit. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy (Photo courtesy of bartekwardziak / Fotolia).
New findings have demonstrated that mammography remains beneficial for women in their 40s. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy.
Researchers from University Hospitals (UH) Case Medical Center (Cleveland, OH, USA) and Case Western Reserve University School of Medicine (Cleveland, OH, USA) have published new findings in the February 2014 issue of American Journal of Roentgenology that mammography is an important detection tool for women in their 40s. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy.
There have been contradictory guidelines recently related to the benefit of yearly mammograms for women in their 40s. The United States Preventive Services Task Force’s guidelines from 2009 recommend against annual screening mammography for women in that age group while the American Cancer Society, American College of Radiology, and other professional societies recommend annual exams beginning at age 40.
“Our findings clearly underscore the impact of neglecting to screen women with mammography for women in their 40s,” said the study’s first author Donna Plecha, MD, director of breast imaging at UH Case Medical Center Seidman Cancer Center and assistant professor at Case Western Reserve School of Medicine. “Foregoing mammography for women in this age group leads to diagnoses of later stage breast cancers. We continue to support screening mammography in women between the ages of 40 and 49 years.”
In the study, the authors compared two groups of women between 40 and 49 years old: women undergoing screening mammography and women with a symptom needing diagnostic workup. The researchers conducted a retrospective chart review of 230 primary breast cancers and found that patients undergoing screening mammography had substantial differences in relation to treatment recommendations, stage at diagnosis and identification of high-risk lesions than symptomatic women needing diagnostic evaluation. They determined that patients in the screened group were diagnosed at earlier stages with smaller tumors and less apt to require chemotherapy and its associated morbidities. They also revealed that screening allows identification of high-risk lesions, which may encourage chemoprevention and lower ensuing breast cancer risk.
Breast cancer is a major health problem and statistics indicate that one in eight women will develop the disease in her lifetime. The stage at which the cancer is detected influences a woman’s likelihood of survival and yearly mammography after the age of 40 enables physicians to identify the smallest abnormalities. In fact, when breast cancer is detected early and limited to the breast, the five-year survival rate is 97%. “Annual screening mammograms starting at the age of 40 saves lives,” concluded Dr. Plecha. “Breast cancers caught in the initial stages by mammography are more likely to be cured and are less likely to require chemotherapy or as extensive surgery.”
Related Links:
University Hospitals Case Medical Center
Researchers from University Hospitals (UH) Case Medical Center (Cleveland, OH, USA) and Case Western Reserve University School of Medicine (Cleveland, OH, USA) have published new findings in the February 2014 issue of American Journal of Roentgenology that mammography is an important detection tool for women in their 40s. According to the study, women between ages 40 and 49 who underwent routine screening mammography were diagnosed at earlier stages with smaller tumors and were less likely to require chemotherapy.
There have been contradictory guidelines recently related to the benefit of yearly mammograms for women in their 40s. The United States Preventive Services Task Force’s guidelines from 2009 recommend against annual screening mammography for women in that age group while the American Cancer Society, American College of Radiology, and other professional societies recommend annual exams beginning at age 40.
“Our findings clearly underscore the impact of neglecting to screen women with mammography for women in their 40s,” said the study’s first author Donna Plecha, MD, director of breast imaging at UH Case Medical Center Seidman Cancer Center and assistant professor at Case Western Reserve School of Medicine. “Foregoing mammography for women in this age group leads to diagnoses of later stage breast cancers. We continue to support screening mammography in women between the ages of 40 and 49 years.”
In the study, the authors compared two groups of women between 40 and 49 years old: women undergoing screening mammography and women with a symptom needing diagnostic workup. The researchers conducted a retrospective chart review of 230 primary breast cancers and found that patients undergoing screening mammography had substantial differences in relation to treatment recommendations, stage at diagnosis and identification of high-risk lesions than symptomatic women needing diagnostic evaluation. They determined that patients in the screened group were diagnosed at earlier stages with smaller tumors and less apt to require chemotherapy and its associated morbidities. They also revealed that screening allows identification of high-risk lesions, which may encourage chemoprevention and lower ensuing breast cancer risk.
Breast cancer is a major health problem and statistics indicate that one in eight women will develop the disease in her lifetime. The stage at which the cancer is detected influences a woman’s likelihood of survival and yearly mammography after the age of 40 enables physicians to identify the smallest abnormalities. In fact, when breast cancer is detected early and limited to the breast, the five-year survival rate is 97%. “Annual screening mammograms starting at the age of 40 saves lives,” concluded Dr. Plecha. “Breast cancers caught in the initial stages by mammography are more likely to be cured and are less likely to require chemotherapy or as extensive surgery.”
Related Links:
University Hospitals Case Medical Center
Latest Radiography News
- World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
- AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
- Higher Chest X-Ray Usage Catches Lung Cancer Earlier and Improves Survival
- AI-Powered Mammograms Predict Cardiovascular Risk
- Generative AI Model Significantly Reduces Chest X-Ray Reading Time
- AI-Powered Mammography Screening Boosts Cancer Detection in Single-Reader Settings
- Photon Counting Detectors Promise Fast Color X-Ray Images
- AI Can Flag Mammograms for Supplemental MRI
- 3D CT Imaging from Single X-Ray Projection Reduces Radiation Exposure
- AI Method Accurately Predicts Breast Cancer Risk by Analyzing Multiple Mammograms
- Printable Organic X-Ray Sensors Could Transform Treatment for Cancer Patients
- Highly Sensitive, Foldable Detector to Make X-Rays Safer
- Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram
- Artificial Intelligence Accurately Predicts Breast Cancer Years Before Diagnosis
- AI-Powered Chest X-Ray Detects Pulmonary Nodules Three Years Before Lung Cancer Symptoms
- AI Model Identifies Vertebral Compression Fractures in Chest Radiographs
Channels
MRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more